Insider Selling as a Buying Opportunity: Waste Management and Ionis Pharmaceuticals

Insider selling in Waste Management (WM) and Ionis Pharmaceuticals (IONS) may be a good thing as it indicates insiders taking profits in stocks with increasingly bullish outlooks. WM, a solid dividend growth machine, and IONS, a commercial-stage biopharma with double-digit growth potential, are pulling back from early 2026 highs, driven by insider selling, and opening entry points for new investors. Both stocks have strong institutional ownership and analyst support, with WM's dividend and IONS' potential blockbuster drug Olezarsen driving their growth.